• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human RBMS2 Polyclonal Antibody

The antibody against RBMS2 was raised in rabbit using the Human RBMS2 as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, WB.

ADC-45893A

The antibody against RBMS2 was raised in rabbit using the Human RBMS2 as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, WB.

$600.00

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADC-45893A ClonalityPolyclonal
Host SpeciesRabbitTarget NameRBMS2
Target SynonymsRBMS2 antibody; SCR3 antibody; RNA-binding motif antibody; single-stranded-interacting protein 2 antibody; Suppressor of CDC2 with RNA-binding motif 3 antibodyFormLiquid
Species ReactivityHuman, Mouse, RatIsotypeIgG
Storage Buffer50% Glycerol, Avoid freeze / thaw cycles., PBS with 0.02% sodium azidePurification MethodAntigen affinity purified
ConjugateNon-conjugatedApplicationELISA, WB
StorageUpon receipt

Immunogen Information


Immunogen DescriptionHuman RBMS2Target SpeciesHuman
Immunogen SequenceComplete sequences for the immunogen, target protein, and peptides are available upon request.Uniprot IDQ15434
Background Information
  • Uniprot Id

    Q15434

  • Target Species

    Human

  • Target Name

    RBMS2

  • Target Full Name

    RNA-binding motif, single-stranded-interacting protein 2

  • Target Subcellular Location

    Nucleus.

  • Target Synonyms

    RBMS2; SCR3; RNA-binding motif; single-stranded-interacting protein 2; Suppressor of CDC2 with RNA-binding motif 3

Inquire Rabbit anti-Human RBMS2 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification